NCT03084211

Brief Summary

Introduction: Current guidelines for treating patients with mild traumatic brain injury (MTBI) recommend a period of cognitive rest and gradual return to usual activities with avoidance of any activity that exacerbates symptoms. However, recent studies have reported prolonged rest beyond 48 hours might hinder MTBI recovery, and there is limited evidence to suggest following guidelines has a positive impact on prognosis. Given the paucity of effective management strategies to prevent post-concussion syndrome (PCS) and emerging evidence of the benefits of exercise in MTBI patients, there is an urgent need for more research on the effectiveness of an early exercise intervention in the acute MTBI patient population as prevention of PCS. Research Question: Among adult (18-64 years) patients presenting to the ED with a discharge diagnosis of acute MTBI (defined by the Zurich consensus statement), does prescribing light exercise (ie: 30 min daily walking) reduce the proportion of patients with PCS at 30 days, compared to standard discharge instructions? Methods: This will be a randomized controlled trial of adult (18-64 years) patients discharged from an academic ED diagnosed with MTBI occurring within 48 hours of the index ED visit. The intervention group will receive discharge instructions prescribing 30 minutes of light exercise (ie: walking) and the control group will be instructed to gradually return to activities. Discharge instructions will be read by the attending physician or ED nurse. Patients will be provided a printed copy of the discharge instructions. Depending on their preferences, patients will be contacted by email or by telephone to complete the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), a validated, 16 item questionnaire. The primary outcome of this study will be the proportion of patients with PCS at 30 days, defined as an increase from baseline of ≥ 3 symptoms on the validated RPQ at 1 month. Secondary outcomes will include change in RPQ from baseline to 72 hours, 7 days, 14 days, 30 days post initial ED visit, number of missed days of school or work and repeat visits to a healthcare provider. To assess compliance with ED discharge instructions, patients will be asked to complete a daily activity journal and will be given fitness tracking devices.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
367

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 20, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

June 19, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2019

Completed
Last Updated

February 20, 2020

Status Verified

February 1, 2020

Enrollment Period

2.3 years

First QC Date

March 13, 2017

Last Update Submit

February 19, 2020

Conditions

Keywords

emergency departmentconcussionhead injury

Outcome Measures

Primary Outcomes (1)

  • proportion of patients with PCS

    Defined as an increase from baseline of ≥ 3 symptoms on the validated Rivermead Post-Concussion Symptoms Questionnaire

    30 days

Secondary Outcomes (3)

  • Change in RPQ from baseline

    72 hours, 7 days, 14 days, 30 days post initial ED visit

  • Days of school or work missed

    72 hours, 7 days, 14 days, 30 days post initial ED visit

  • Return visits to a health care provider

    72 hours, 7 days, 14 days, 30 days post initial ED visit

Study Arms (2)

Control Group

NO INTERVENTION

The control group will be instructed to gradually return to activities.

Prescribed Light Exercise Group

EXPERIMENTAL

Intervention: Prescribed Light Exercise Group will receive discharge instructions prescribing 30 minutes of light exercise (ie: walking).

Other: Light exercise discharge instructions

Interventions

Participants in the intervention group will receive discharge instructions prescribing light exercise following mild traumatic brain injury.

Prescribed Light Exercise Group

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \- MTBI occurring within 48 hours of the index emergency department visit

You may not qualify if:

  • Acute intracranial injury identified on head CT
  • Multisystem injuries prohibiting light exercise
  • Existing medical condition that would compromise ability to participate in light exercise
  • GCS \< 15 at time of ED discharge
  • Underlying neurological condition resulting in communication difficulties
  • Insurmountable language barrier
  • Inability to follow-up via telephone
  • Alcohol or drug intoxication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Hospital

Toronto, Ontario, M5G 1X5, Canada

Location

Related Publications (1)

  • Varner CE, Thompson C, de Wit K, Borgundvaag B, Houston R, McLeod S. A randomized trial comparing prescribed light exercise to standard management for emergency department patients with acute mild traumatic brain injury. Acad Emerg Med. 2021 May;28(5):493-501. doi: 10.1111/acem.14215. Epub 2021 Feb 28.

MeSH Terms

Conditions

Brain ConcussionEmergenciesCraniocerebral Trauma

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, NonpenetratingDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Catherine Varner, MD MSc

    Sinai Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician Scientist

Study Record Dates

First Submitted

March 13, 2017

First Posted

March 20, 2017

Study Start

June 19, 2017

Primary Completion

October 3, 2019

Study Completion

October 3, 2019

Last Updated

February 20, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

No IDP will be shared with other researchers.

Locations